Novel iso-ergoline derivatives
AssigneeMAP Pharmaceuticals, Inc.
InventorsJian Zhang, Robert O. Cook
Life of this patent
Estimating the term…
Loading patent…
AssigneeMAP Pharmaceuticals, Inc.
InventorsJian Zhang, Robert O. Cook
Estimating the term…
Provided herein are novel iso-ergoline derivatives and compositions thereof. In other embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, migraine using the compounds and compositions disclosed herein. In still other embodiments, provided herein are methods of agonizing receptors such as, for example, the 5-HT1D and/or the 5-HT1Breceptor, without agonizing the 5-HT2B receptor using the compounds and compositions disclosed herein. In still other embodiments, provided herein are methods of antagonizing or inhibiting activity at receptors such as, for example, the adrenergic alpha2A and/or the alpha2Breceptors using the compounds and compositions disclosed herein.
A compound of Formula (I) or (II):
Dependencies are inferred from the claim text.